Document
IPR2019-00695, No. 1020-20 Exhibit - Nalox1020 Barton 2002 (P.T.A.B. Feb. 19, 2019)
Cite Document
IPR2019-00695, No. 1020-20 Exhibit - Nalox1020 Barton 2002 (P.T.A.B. Feb. 19, 2019)
+ More Snippets
Document
IPR2019-00695, No. 1030-30 Exhibit - Nalox1030 Freise 2012 (P.T.A.B. Feb. 19, 2019)
Cite Document
IPR2019-00695, No. 1030-30 Exhibit - Nalox1030 Freise 2012 (P.T.A.B. Feb. 19, 2019)
+ More Snippets
Document
IPR2019-00695, No. 1035-34 Exhibit - Nalox1035 Kerr 2008 (P.T.A.B. Feb. 19, 2019)
Cite Document
IPR2019-00695, No. 1035-34 Exhibit - Nalox1035 Kerr 2008 (P.T.A.B. Feb. 19, 2019)
+ More Snippets
Document
IPR2019-00695, No. 1051-50 Exhibit - Nalox1051 Sabzghabaee 2014 (P.T.A.B. Feb. 19, 2019)
Cite Document
IPR2019-00695, No. 1051-50 Exhibit - Nalox1051 Sabzghabaee 2014 (P.T.A.B. Feb. 19, 2019)
+ More Snippets
Document
IPR2019-00695, No. 1017-17 Exhibit - Nalox1017 Alabama EMS Protocols 2013 (P.T.A.B. Feb. 19, 2019)
Cite Document
IPR2019-00695, No. 1017-17 Exhibit - Nalox1017 Alabama EMS Protocols 2013 (P.T.A.B. Feb. 19, 2019)
+ More Snippets
Document
IPR2019-00695, No. 1010-10 Exhibit - Nalox1010 Djupesland 2013 (P.T.A.B. Feb. 19, 2019)
Cite Document
IPR2019-00695, No. 1010-10 Exhibit - Nalox1010 Djupesland 2013 (P.T.A.B. Feb. 19, 2019)
+ More Snippets
Document
IPR2019-00695, No. 1057-55 Exhibit - Nalox1057 US Patent No 5,813,570 (P.T.A.B. Feb. 19, 2019)
Cite Document
IPR2019-00695, No. 1057-55 Exhibit - Nalox1057 US Patent No 5,813,570 (P.T.A.B. Feb. 19, 2019)
+ More Snippets
Document
IPR2019-00695, No. 1021-21 Exhibit - Nalox1021 Barton 2005 (P.T.A.B. Feb. 19, 2019)
Cite Document
IPR2019-00695, No. 1021-21 Exhibit - Nalox1021 Barton 2005 (P.T.A.B. Feb. 19, 2019)
+ More Snippets
Document
IPR2019-00695, No. 1048-47 Exhibit - Nalox1048 Role of Naloxone 76 Fed Reg 71,348 (P.T.A.B. Feb. 19, 2019)
Cite Document
IPR2019-00695, No. 1048-47 Exhibit - Nalox1048 Role of Naloxone 76 Fed Reg 71,348 (P.T.A.B. Feb. 19, 2019)
+ More Snippets
Document
IPR2019-00694, No. 1039-38 Exhibit - Nalox1039 Merck Index (P.T.A.B. Feb. 19, 2019)
Cite Document
IPR2019-00694, No. 1039-38 Exhibit - Nalox1039 Merck Index (P.T.A.B. Feb. 19, 2019)
+ More Snippets
Document
IPR2019-00694, No. 1002-2 Exhibit - Nalox1002 Donovan Declaration 694 (P.T.A.B. Feb. 19, 2019)
Cite Document
IPR2019-00694, No. 1002-2 Exhibit - Nalox1002 Donovan Declaration 694 (P.T.A.B. Feb. 19, 2019)
+ More Snippets
Document
IPR2019-00694, No. 1028-28 Exhibit - Nalox1028 2002 FDA Guidance (P.T.A.B. Feb. 19, 2019)
Cite Document
IPR2019-00694, No. 1028-28 Exhibit - Nalox1028 2002 FDA Guidance (P.T.A.B. Feb. 19, 2019)
+ More Snippets
Document
IPR2019-00694, No. 1009-9 Exhibit - Nalox1009 WO 0062,757 Davies (P.T.A.B. Feb. 19, 2019)
Cite Document
IPR2019-00694, No. 1009-9 Exhibit - Nalox1009 WO 0062,757 Davies (P.T.A.B. Feb. 19, 2019)
+ More Snippets
Document
NARCAN, 208411, Letter (Orange Book Aug. 6, 2020)
Cite Document
NARCAN, 208411, Letter (Orange Book Aug. 6, 2020)
+ More Snippets
Document
NARCAN, 208411, Label (Orange Book Aug. 6, 2020)
Cite Document
NARCAN, 208411, Label (Orange Book Aug. 6, 2020)
+ More Snippets